Recent Articles
September 01, 2008
CHICAGO—A 24-hour analgesic score prior to palliative treatment in patients with hormone- refractory prostate cancer (HRPC) potentially could be used in place of daily average analgesic scores, according to researchers.
September 01, 2008
CHICAGO—An experimental oral agent called abiraterone acetate, used in combination with prednisone, can decrease serum androgen levels to undetectable levels in men who have progressive metastatic castration-resistant prostate cancer (CRPC) following failure of docetaxel-based chemotherapy, according to new data.
September 01, 2008
SAN FRANCISCO—Overweight men are no more likely to be infertile than normal-weight men, according to study findings presented here at the annual meeting of The Endocrine Society.
September 01, 2008
ORLANDO—Morbid obesity can cause sexual dysfunction in men, but new findings suggest that weight loss resulting from gastric bypass surgery may normalize sexual function.
September 01, 2008
SAN FRANCISCO—Low serum testosterone levels may be associated with an increased risk of death from cardiovascular causes and cancer, independent of age and other risk factors, according to a recent population-based study. Thus low testosterone may be a predictive marker for these causes of death.
September 01, 2008
CHICAGO—Sunitinib (Sutent) remains a reference standard for the first-line treatment of metastatic renal cell carcinoma (RCC), with updated findings from a phase 3 trial confirming the superior efficacy of this agent over interferon-alfa, researchers reported here at the American Society of Clinical Oncology annual meeting.
August 28, 2008
ORLANDO—Elderly men with moderate or severe lower urinary tract symptoms (LUTS) are at significantly greater risk for falls, and the risk dramatically increases as the symptoms worsen, data show.
August 28, 2008
ORLANDO—Men who experience erectile dysfunction (ED) following prostate cancer surgery usually do not have coverage for ED treatment even though their insurance policies cover surgery for prostate cancer, according to a study.
August 28, 2008
ORLANDO—Injections of the Maxi-K gene into the penis of men with erectile dysfunction (ED) appears to be safe and shows potential for improving erectile function, data from a phase I study suggest.
August 28, 2008
ORLANDO—For the first time, clinicians have an evidence-based definition of premature ejaculation (PE).